Diphtheria and tetanus toxoids and acellular pertussis vaccine was licensed for use
On Dec. 17, 1991, the Diphtheria and tetanus toxoids and acellular pertussis vaccine (Acel-Imune by Lederle) was licensed…
On Dec. 17, 1991, the Diphtheria and tetanus toxoids and acellular pertussis vaccine (Acel-Imune by Lederle) was licensed…
On Nov. 22, 1991, the Immunization Practices Advisory Committee (ACIP) published recommendations for routine hepatitis B vaccination for…
On Jan. 11, 1991, recommendations of Immunization Practices Advisory Committee (ACIP) for routine Hib vaccination for infants beginning…
In 1991, the last case of indigenous polio in the Western Hemisphere occurred in a 5-year-old boy, Luis…
In 1991, The Northwestern University Cancer Center was dedicated through an endowment gift from Ann and Robert H….
On Dec. 13, 1990, the U.S. Food and Drug Administration (FDA) approved Haemophilus b Conjugate Vaccine (Meningococcal Protein…
On Apr. 13, 1990, the Immunization Practices Advisory Committee (ACIP) recommendations for use of any of the three…
In 1990, the Global Polio Laboratory Network (GPLN) was formally established by the World Health Organization (WHO), national…
On Dec. 15, 1989, the live, oral typhoid vaccine (Ty21a, Vivotif Berna by Swiss Serum Institute) was licensed….
On Aug. 28, 1989, a second recombinant hepatitis B vaccine, Engerix-B (SmithKlineBeecham), was approved for use in the…
In 1989, recommendations for routine 2nd doses of measles-containing vaccine were issued by both ACIP and the American…
In 1989, the U.S. Centers for Disease Control and Prevention (CDC) established a World Health Organization (WHO) collaborating…
On Dec. 21, 1988, the conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed. Prior to…
On Jan. 22, 1988, the Immunization Practices Advisory Committee (ACIP) recommended the Hib conjugate vaccine be provided to…
In 1988, the National Vaccine Injury Compensation Program (NVICP) was established to provide compensation following a vaccine-related adverse…
On Dec. 22, 1987, the protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught) was licensed.
On Nov. 14, 1986, the U.S. Congress created the National Vaccine Program (NVP) to coordinate the vaccine research…
On Jul. 23, 1986, the Recombinant hepatitis B vaccine (Recombivax HB by Merck) was licensed. Using recombinant DNA…
In 1986, while teaching a graduate course at the University of Alberta, Dr. Tyrrell found clues that might…
In 1986, the National Childhood Vaccine Injury Act was enacted by Congress. The Department of Health and Human…
In 1985, Rotary International established its PolioPlus program, which held two fundraising events. Rotary has contributed over $500…
In 1985, the CDIPD was founded as an NIH-NIAID-supported Tropical Disease Research Unit (TDRU) at University of California,…
On Sept. 1, 1984, with the enactment of P.L. 98-369 by the U.S. Congress, coverage under Part B…
On Jun. 30, 1983, the U.S. Food and Drug Administration (FDA) licensed two enhanced pneumococcal polysaccharide vaccines (Pneumovax…
in May 1983, President Ronald Reagan signed into law a bill that established the Foundation for the Advancement…
In 1983, Hollister-Stier Laboratories became a division of the Miles Pharmaceutical Group. Hollister-Stier Laboratories, located in Spokane, was…
In 1982, the Small Business Innovation Research (SBIR) program, administered by the U.S. Small Business Administration (SBA), was…
In 1982, the first recombinant DNA vaccine for livestock was developed. An advantage of the vaccines made through…
In 1982, the first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were…
In 1982, the U.S. Centers for Disease Control and Prevention (CDC) reported an all-time low of measles cases,…